Trends in multidrug-resistant tuberculosis

• Published in: Journal of Venomous Animals and Toxins including Tropical Diseases
• Main Authors: I. M. F. Dias-Baptista, S. M. R. S. Usó, J. Marcondes-Machado
• Format: Article in Journal/Newspaper
• Language: English
• Published: SciELO 2008
• Subjects: Tuberculosis; MDR-TB; XDR-TB; DOTS; DOTS-Plus; Arctic medicine. Tropical medicine; RC955-962; Toxicology. Poisons; RA1190-1270; Zoology; QL1-991; Arctic
• Online Access: https://doi.org/10.1590/S1678-91992008000200003; https://doaj.org/article/a08a634111fe4a878542616ff3bdb042

Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The extent and burden of MDR-TB varies significantly from country to country and region to region. Globally, about three per cent of all newly diagnosed patients have MDR-TB and the proportion is higher in patients who had previously received anti-tuberculosis (anti-TB) treatment reflecting the failure of programs designed to ensure complete cure of patients with tuberculosis. The management of MDR-TB is a challenge that should be undertaken by experienced clinicians at centers equipped with reliable laboratory services and implementation of DOTS-Plus strategy.